All Episodes
Oncology Today with Dr Neil Love — 523 episodes · page 1 of 6
Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1
Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus
Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Non-Small Cell Lung Cancer — Targeting KRAS G12C
Prostate Cancer — The Optimal Use of Hormonal Therapy
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3
AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists
Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
Metastatic Triple-Negative Breast Cancer — Patterns of Care
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress
HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway
AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances
Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Metastatic Bladder Cancer — Rapid Case Review Issue 6
For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
Metastatic Bladder Cancer — Rapid Case Review Issue 5
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting
For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2
For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Endometrial Cancer — An Interview with Dr Floor J Backes
For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
Prostate Cancer — Fifth Annual National General Medical Oncology Summit
Colorectal Cancer — Fifth Annual National General Medical Oncology Summit
Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit
Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy
Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium